Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Clinical trial NCT03893565 · TERMINATED

Trial details

NCT number: NCT03893565
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2019-05-06
Primary completion: 2021-05-17
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.